Clinical Trial Update: Effect of Antifibrotic Therapy on Regression of Myocardial Fibrosis After Transcatheter Aortic Valve Implantation (TAVI) in Aortic Stenosis Patients With High Fibrotic Burden [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating antifibrotic therapy to induce regression of myocardial fibrosis after TAVI in patients with severe aortic stenosis and high fibrotic b…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Aortic Stenosis

Snippet

Sponsor: University Medical Center Goettingen | Conditions: Aortic Stenosis, Severe | Phase 3 | Status: UNKNOWN